[Neurophysiological study of Ro-05-4023].
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D002540:Cerebral Cortex / Q000502:physiology; D004558:Electric Stimulation; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006624:Hippocampus / Q000502:physiology; D008027:Light; D010433:Pentylenetetrazole; D012154:Reticular Formation / Q000502:physiology; D012640:Seizures / Q000139:chemically induced; D012890:Sleep / Q000187:drug effects; D013788:Thalamus; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014793:Visual Cortex / Q000502:physiology
D014149:Tranquilizing Agents; D010433:Pentylenetetrazole
Etude neurophysiologique du Ro-05-4023.